Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2530 of 6351
-
Hunterase extended trial shows promise for managing hunter syndrome
Disease control CompletedThe objective of this study is to assess the long-term safety and efficacy of Hunterase for approximately 1 year in subjects who completed the end of study (EOS) visit (Visit 54) tests in the Phase 3 Hunterase study and patients who received Hunterase for more than 6 months
Phase 3 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can cuddling save tiny babies? trial tests early kangaroo care
Disease control Stopped earlyThe mortality effect of kangaroo mother care in stable newborns \<2000g is well established but mortality effect in unstable newborns is not conclusively known. This pragmatic clinical trial aims to investigate the mortality and clinical effects of early continuous Kangaroo Mothe…
Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Personalized brain zaps plus therapy shows promise for depression
Symptom relief CompletedBackground: Repetitive transcranial magnetic stimulation (rTMS) is a treatment for depression. It stimulates the brain. Researchers want to see if using magnetic resonance imaging (MRI) scans helps locate the best area for rTMS in each person. They also want to find other ways t…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Can stem cells repair a scarred liver? new trial hopes so
Disease control By invitation onlyThe study aims to evaluate the effect of allogeneic mesenchymal stem cell therapy on patients who suffered from liver cirrhosis caused by Hepatitis B.
Phase 1/2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can a drug shrink precancerous breast cells before surgery?
Disease control CompletedThis study is evaluating how ruxolitinib affects premalignant breast cells. One half of the study participants will receive ruxolitinib for approximately 15 days, and the other half will receive a placebo (sugar pill) for approximately 15 days. Once study participants have comple…
Phase 2 • Sponsor: Julie Nangia • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New scan may better spot ovarian cancer tumors before surgery
Diagnosis OngoingThis trial studies how well positron emission tomography/magnetic resonance (PET/MR) versus contrast enhanced computerized tomography (CECT) scans work in locating ovarian cancer tumors in patients with known or suspected ovarian cancer. PET, MR, and CECT scans use different meth…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
Can exercise, diet, or a pill help older diabetics stay strong?
Disease control CompletedPrimary objective: To assess the effects of a modified plant-based Mediterranean diet (vegeterranean diet), circuit resistance training (CRT) and empagliflozin alone or in combination on metabolic and physical function in elderly subjects with type 2 diabetes. The rationale for t…
Phase 4 • Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Disease control
Last updated Jun 26, 2026 14:21 UTC
-
New drug shows promise for Long-Term control of cushing syndrome
Disease control OngoingThis is an open-label extension study to evaluate the long-term safety of relacorilant in patients with endogenous Cushing syndrome who successfully completed participation in a Corcept-sponsored study of relacorilant and may benefit from continuing treatment.
Phase 2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Momelotinib access expanded for myelofibrosis patients in Long-Term safety study
Disease control OngoingThe primary objective of this study is to provide extended access and assess long-term safety of momelotinib (MMB) in participants with primary myelofibrosis (PMF) or post-polycythemia vera or post-essential thrombocythemia myelofibrosis (Post-PV/ET MF) enrolled in studies GS-US-…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Personalized weight loss: Gene-Tailored drug shows promise
Disease control CompletedObesity is a widespread disease with increasing prevalence and associated with serious secondary complications. So far, the origin of the disease, regardless of an existing positive energy balance, is not fully understood. In addition to environmental factors, the genetic backgro…
Phase 2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Belly wall transplants: a new frontier in organ transplants?
Disease control Recruiting nowThe purpose of this protocol is to determine the safety and efficacy of abdominal wall transplantation as a treatment for the reconstruction of abdominal wall defects. Abdominal wall transplantation may be performed alone or in combination with another transplant.
Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a common heart drug stop diabetes-related heart failure?
Disease control CompletedThis study will advance the investigator's knowledge of the integrated cardiorenal and humoral physiology in type 2 diabetic patients with and without pre-clinical diastolic dysfunction, and test a novel therapeutic strategy which may prevent a progression to symptomatic Stage C …
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Brain scan study seeks clues to memory decline in older adults
Knowledge-focused Recruiting nowThe purpose of this research study is to understand the factors that underlie changes in thinking and memory with increasing age. The investigators will test the usefulness of MRI, PET, and cognitive testing in detecting subtle changes in the brain that precede cognitive decline.…
Phase 3 • Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Promising combo tackles tough cancers in early trial
Disease control CompletedThis research study is studying an investigational combination of drugs as a possible treatment for advanced solid tumors: melanoma, ovarian, renal, or colorectal cancer. The drugs involved in this study are: * Pembrolizumab * AMG386
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New eye drops aim to soothe dry eye in bone marrow transplant patients
Symptom relief CompletedThe purpose of this Phase 1/2 study is to compare the safety and tolerability of four times a day (QID) dosing of a non-preserved topical ocular drop formulation of 10 vol/vol % and 30 vol/vol % of FD hPL to vehicle control eye drops in patients with Dry Eye Disease (DED) seconda…
Phase 1/2 • Sponsor: Cambium Bio Limited • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Hair loss breakthrough? study tests top treatments for CCCA
Disease control Recruiting nowThe objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment groups
Phase 4 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a 14-Hour overnight fast help childhood cancer survivors?
Disease control OngoingThe purpose of this study is to test whether regularly not eating for at least 14 hours overnight ("intermittent fasting") is feasible and can improve blood sugar.
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New biopsy test could predict chemo success in breast cancer
Knowledge-focused OngoingThe current study aims to provide validation results of RNA Disruption Assay (RDA) as a tumour response assessment tool that uses tumour core biopsies taken starting from 35 +/- 4 days after the initiation of neoadjuvant chemotherapy.
Sponsor: Rna Diagnostics Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Blood test may cut hospital stays for preeclampsia
Diagnosis CompletedThe aim of the PRECOG study is to determine in a prospective interventional randomized study whether the implementation of a predictive test based on the sFLT-1/PlGF ratio improves perinatal care and reduces costs, in patients with suspected preeclampsia before 35 weeks of gestat…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
New bone graft could improve spinal fusion outcomes
Disease control OngoingThe aim of this trial is to evaluate if P-15L bone graft (investigational device) is not inferior in effectiveness and safety to local autologous bone (and allograft where necessary) as an extender (control device) when applied in instrumented transforaminal lumbar interbody fusi…
Sponsor: CeraPedics, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC